-
1.发明申请TOPICAL OPHTHALMIC FORMULATIONS CONTAINING DOXEPIN DERIVATIVES FOR TREATING ALLERGIC EYE DISEASES 审中-公开含有DOXEPIN衍生物用于治疗过敏性眼病的局部OPHTHALMIC配方
公开(公告)号：WO1996039147A2
公开(公告)日：1996-12-12
申请号：PCT/US1996006289
申请日：1996-05-03
Applicant: ALCON LABORATORIES, INC.
Inventor： ALCON LABORATORIES, INC. , YANNI, John, Michael , ROBERTSON, Stella, M. , HAYAKAWA, Eiji , NAKAKURA, Masashi
IPC: A61K31/645
CPC classification number: A61K31/00
Abstract: Topical ophthalmic formulations of the invention contain as an active ingredient 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid or a pharmaceutically acceptable salt thereof. The formulations are useful for treating allergic eye diseases such as allergic conjunctivitis, vernal conjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis.
Abstract translation: 本发明的局部眼用制剂含有作为活性成分的11-（3-二甲基氨基亚丙基）-6,11-二氢二苯并[b，e]氧杂七环素-2-乙酸或其药学上可接受的盐。 该制剂可用于治疗过敏性眼部疾病如过敏性结膜炎，春季结膜炎，春季角膜结膜炎和巨型乳头状结膜炎。
-
2.发明公开TOPICAL OPHTHALMIC FORMULATIONS CONTAINING DOXEPIN DERIVATIVES FOR TREATING ALLERGIC EYE DISEASES 失效对于局部使用制剂对眼睛DOXEPINDERIVATE CONTAIN过敏性眼病治疗
公开(公告)号：EP0799044A2
公开(公告)日：1997-10-08
申请号：EP96915500.0
申请日：1996-05-03
Applicant: ALCON LABORATORIES, INC. , Kyowa Hakko Kogyo Co., Ltd.
Inventor： YANNI, John, Michael , ROBERTSON, Stella, M. , HAYAKAWA, Eiji , NAKAKURA, Masashi
CPC classification number: A61K31/00
Abstract: Topical ophthalmic formulations of the invention contain as an active ingredient 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid or a pharmaceutically acceptable salt thereof. The formulations are useful for treating allergic eye diseases such as allergic conjunctivitis, vernal conjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis.
-
3.发明授权TOPICAL OPHTHALMIC FORMULATIONS CONTAINING OLOPATADINE FOR TREATING ALLERGIC EYE DISEASES 失效制剂外用对奥洛他定CONTAIN过敏性眼病治疗眼睛
公开(公告)号：EP0799044B1
公开(公告)日：2002-07-24
申请号：EP96915500.1
申请日：1996-05-03
Applicant: ALCON LABORATORIES, INC. , KYOWA HAKKO KOGYO CO., Ltd.
Inventor： YANNI, John, Michael , ROBERTSON, Stella, M. , HAYAKAWA, Eiji , NAKAKURA, Masashi
CPC classification number: A61K31/00
Abstract: Topical ophthalmic formulations of the invention contain as an active ingredient 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid or a pharmaceutically acceptable salt thereof. The formulations are useful for treating allergic eye diseases such as allergic conjunctivitis, vernal conjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis.
-
-
Search Results
3
records
(took 0.02 seconds)
